Thermo Fisher Scientific
The Clinical Study Planning & Scheduling Lead leads study planning and portfolio scheduling across multiple Clinical Research Units, focusing on early-phase clinical studies. This role serves as the central owner of integrated site study calendars, coordinating the placement of awarded and prospective studies while evaluating scheduling changes to maintain accurate, executable plans. The position involves balancing various site constraints and operational factors to identify scheduling risks and optimize available capacity.
Headquarters
Waltham, Massachusetts, United States
Company Size
10001+ employees
Founded
1956
Thermo Fisher Scientific is a global American multinational that provides scientific instruments, reagents, consumables, software, and services for life sciences, clinical diagnostics, research, and applied markets. Formed in 2006 by the merger of Thermo Electron and Fisher Scientific, the company supplies lab equipment (e.g., mass spectrometers, chromatographs, sequencing and PCR platforms), specialty chemicals and reagents, diagnostics, and contract development and manufacturing (CDMO) services for pharmaceutical and biotech customers. Its mission is to enable customers to make the world healthier, cleaner, and safer by delivering integrated technology, support, and end-to-end solutions across research, clinical, and production workflows. Thermo Fisher operates globally with extensive sales, manufacturing, and service networks.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Thermo Fisher Scientific.
Thermo Fisher Scientific didn’t post a salary, so this is our estimate from similar listings.